Blood online
Home About Blood Authors Subscriptions Permission Advertising Public Access contact us
 

 
Advanced
Current Issue
First Edition
Future Articles
Archives
Submit to Blood
Search
American Society of Hematology
Meeting Abstracts
Email Alerts
Prepublished online as a Blood First Edition Paper on July 18, 2002; DOI 10.1182/blood-2002-04-1284.

This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
2002-04-1284v1
100/12/4098    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Right arrow Rights and Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Spaggiari, G. M.
Right arrow Articles by Poggi, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Spaggiari, G. M.
Right arrow Articles by Poggi, A.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Submitted April 30, 2002
Accepted July 9, 2002

Soluble HLA class I induces NK cell apoptosis upon the engagement of killer activating HLA class I receptors through FasL/Fas interaction

Grazia Maria Spaggiari, Paola Contini, Alessandra Dondero, Roberta Carosio, Francesco Puppo, Francesco Indiveri, Maria Raffaella Zocchi, and Alessandro Poggi*

Laboratory of Immunology, National Institute for Cancer Research, Genoa, Italy
Department of Internal Medicine, University of Genoa, Genoa, Italy
Laboratory of Tumor Immunology, San Raffaele Institute, Milan, Italy

* Corresponding author; email: poggi{at}vega.cba.unige.it.

The engagement of the activating isoforms of C-type Lectin Inhibitory Receptor (CLIR) or Killer Ig-like receptor (KIR) by their natural ligands, represented by soluble HLA-I (sHLA-I) molecules induced programmed cell death of NK cells. Indeed, NK cell apoptosis elicited by either putative HLA-E and HLA-F (sHLA-I non-(A,B,C,G)) or sHLA-I Cw4 or Cw3 from untransfected or Cw4 or Cw3 alleles transfected HLA-A-,B-,C-,G-,E+,F+ 721.221 lymphoblastoid cell line respectively, was blocked by covering the corresponding activating receptor with either anti-CLIR or anti-KIR specific mAbs. After sHLA-I/activating receptor interaction, NK cells produced and released FasL which in turn led to NK cell apoptosis by interacting with Fas at the NK cell surface. Blocking anti-Fas mAb, or anti-FasL mAb, inhibited sHLA-I-mediated apoptosis via activating receptor in NK cell clones. This apoptosis was inhibited by NK cell treatment with cyclosporin A while this drug had no effect on activating receptor-mediated activation of cytolysis. Conversely, concanamycin A, an inhibitor of vacuolar type H+-ATPase of granules, inhibited activating receptor-induced NK cell cytolysis, suggesting that activating receptor-mediated apoptosis and cytolysis can use different intracellular pathways. Furthermore, a large amount of IFN-{gamma} was detectable in culture supernatant of activating receptor+ NK cells incubated with the appropriate sHLA-I ligand. Again, cyclosporin A, but not concanamycin A, strongly reduced activating receptor-mediated IFN-{gamma} production. This suggests that activating receptor-induced apoptosis of NK cell could play a role in eliminating potentially harmful NK cell clones and, at the same time, it leads to production of IFN-{gamma}, an anti-viral cytokine, able to amplify immune responses.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
J. Immunol.Home page
A. K. Moesta, L. Abi-Rached, P. J. Norman, and P. Parham
Chimpanzees Use More Varied Receptors and Ligands Than Humans for Inhibitory Killer Cell Ig-Like Receptor Recognition of the MHC-C1 and MHC-C2 Epitopes
J. Immunol., March 15, 2009; 182(6): 3628 - 3637.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
H. B. Bernstein, M. C. Plasterer, S. E. Schiff, C. M. R. Kitchen, S. Kitchen, and J. A. Zack
CD4 Expression on Activated NK Cells: Ligation of CD4 Induces Cytokine Expression and Cell Migration
J. Immunol., September 15, 2006; 177(6): 3669 - 3676.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
A. Jewett, N. A. Cacalano, C. Head, and A. Teruel
Coengagement of CD16 and CD94 receptors mediates secretion of chemokines and induces apoptotic death of naive natural killer cells.
Clin. Cancer Res., April 1, 2006; 12(7 Pt 1): 1994 - 2003.
[Abstract] [Full Text] [PDF]


Home page
Mult SclerHome page
E Fainardi, R Rizzo, L Melchiorri, M Castellazzi, E Paolino, M R Tola, E Granieri, and O R Baricordi
Intrathecal synthesis of soluble HLA-G and HLA-I molecules are reciprocally associated to clinical and MRI activity in patients with multiple sclerosis
Multiple Sclerosis, February 1, 2006; 12(1): 2 - 12.
[Abstract] [PDF]


Home page
J. Immunol.Home page
P. Contini, M. Ghio, A. Merlo, A. Poggi, F. Indiveri, and F. Puppo
Apoptosis of Antigen-Specific T Lymphocytes upon the Engagement of CD8 by Soluble HLA Class I Molecules Is Fas Ligand/Fas Mediated: Evidence for the Involvement of p56lck, Calcium Calmodulin Kinase II, and Calcium-Independent Protein Kinase C Signaling Pathways and for NF-{kappa}B and NF-AT Nuclear Translocation
J. Immunol., December 1, 2005; 175(11): 7244 - 7254.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
A. Poggi, C. Prevosto, A.-M. Massaro, S. Negrini, S. Urbani, I. Pierri, R. Saccardi, M. Gobbi, and M. R. Zocchi
Interaction between Human NK Cells and Bone Marrow Stromal Cells Induces NK Cell Triggering: Role of NKp30 and NKG2D Receptors
J. Immunol., November 15, 2005; 175(10): 6352 - 6360.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
P. Schierloh, N. Yokobori, M. Aleman, R. M. Musella, M. Beigier-Bompadre, M. A. Saab, L. Alves, E. Abbate, S. S. de la Barrera, and M. C. Sasiain
Increased Susceptibility to Apoptosis of CD56dimCD16+ NK Cells Induces the Enrichment of IFN-{gamma}-Producing CD56bright Cells in Tuberculous Pleurisy
J. Immunol., November 15, 2005; 175(10): 6852 - 6860.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
A. Poggi, A.-M. Massaro, S. Negrini, P. Contini, and M. R. Zocchi
Tumor-Induced Apoptosis of Human IL-2-Activated NK Cells: Role of Natural Cytotoxicity Receptors
J. Immunol., March 1, 2005; 174(5): 2653 - 2660.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
Y. Huang, F. Rezzoug, P. M. Chilton, H. L. Grimes, D. E. Cramer, and S. T. Ildstad
Matching at the MHC class I K locus is essential for long-term engraftment of purified hematopoietic stem cells: a role for host NK cells in regulating HSC engraftment
Blood, August 1, 2004; 104(3): 873 - 880.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
J. P. Goodridge, C. S. Witt, F. T. Christiansen, and H. S. Warren
KIR2DL4 (CD158d) Genotype Influences Expression and Function in NK Cells
J. Immunol., August 15, 2003; 171(4): 1768 - 1774.
[Abstract] [Full Text] [PDF]



 click for free articles
home about blood authors subscriptions permissions advertising public access contact us
  Copyright © 2002 by American Society of Hematology         Online ISSN: 1528-0020